Smith Alan K.

Avg. Two Year Performance

No purchase track record

86% Avg. Sale Return

36% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	36%	21%	23%	51%	86%
Sale Success Rate	2 of 2	2 of 2	2 of 2	2 of 2	2 of 2

Bellicum Pharmaceuticals, Inc

Drugs » Biotechnology

EVP, Technical Operations:

Holdings: 6.96K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--